Known to improve the function of nerve cells in the brain, Reminyl is designed to manage the symptoms of Alzheimer’s Dementia. On the other hand, Amaryl is a drug intended to manage blood sugar levels among diabetic patients. In a 2004 letter by the U.S. Food and Drug Administration (FDA), the agency warned pharmacists to take extra caution in dispensing these drugs, as there have been cases wherein these drugs were dispensed interchangeably.
According to the FDA, patients who took Amaryl instead of Reminyl were at highest risk of hypoglycemia, which may lead to coma and death when left unmanaged. On the other hand, diabetic patients who took Reminyl instead of Amaryl were at risk of hyperglycemia, or high blood glucose. Amaryl’s effects on the central nervous system can also become apparent through diarrhea and nausea.
If you believe a negligent pharmacy staff has caused you to suffer adversely from the physical, emotional, and financial repercussions of a pharmacy error, a lawyer at Habush Habush & Rottier S.C. ® might be able to help you seek the compensation you believe you deserve. Call our Milwaukee office at (414) 271-0900 for a free case consultation.